A. Rubagotti - Publications, H-index & Citations

A. Rubagotti

university of genoa

40H指数

198论文数

6.0K被引数

收录论文 26

发表时间

The EsomiR project: A case control study to assess the role of exosomal miRNAs in breast cancer cancerogenesis

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Cardinali, Barbara; Piccioli, Patrizia; Boccardo, Francesco; Rubagotti, Alessandra; Zinoli, Linda; Sciutto, Andrea; Coco, Simona; Chiorino, Giovanna; Ostano, Paola; Sehovic, Emir; Cavalieri, Zita; Bruzzo, Cristina; Marconi, Silvia; Tasso, Roberta; Quarto, Rodolfo; Ceresa, Davide; Malatesta, Paolo; Del Mastro, Lucia

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2018-01-09

OAAI

Cavo, Alessia; Rubagotti, Alessandra; Zanardi, Elisa; Fabbroni, Chiara; Zinoli, Linda; Di Meglio, Antonio; Arboscello, Eleonora; Bellodi, Andrea; Spallarossa, Paolo; Cattrini, Carlo; Messina, Carlo; Boccardo, Francesco

Targeting androgen-independent pathways: new chances for patients with prostate cancer?

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2017-10-01

OAAI

Cattrini, C.; Zanardi, E.; Vallome, G.; Cavo, A.; Cerbone, L.; Di Meglio, A.; Fabbroni, C.; Latocca, M. M.; Rizzo, F.; Messina, C.; Rubagotti, A.; Barboro, P.; Boccardo, F.

The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome

BMC CANCER

IF3.4

2016-02-12

OAAI

Nuzzo, P. V.; Rubagotti, A.; Zinoli, L.; Salvi, S.; Boccardo, S.; Boccardo, F.

Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 快速增殖的早期乳腺癌患者开始辅助化疗的时间

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Farolfi, Alberto; Scarpi, Emanuela; Rocca, Andrea; Mangia, Anita; Biglia, Nicoletta; Gianni, Lorenzo; Tienghi, Amelia; Valerio, Maria Rosaria; Gasparini, Giampietro; Amaducci, Laura; Faedi, Marina; Baldini, Editta; Rubagotti, Alessandra; Maltoni, Roberta; Paradiso, Angelo; Amadori, Dino

Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2015-06-04

OAAI

Boccardo, Francesco; Rubagotti, Alessandra; Nuzzo, Pier Vitale; Argellati, Francesca; Savarino, Grazia; Romano, Paolo; Damonte, Gianluca; Rocco, Mattia; Profumo, Aldo

Safety of antiandrogen therapy for treating prostate cancer

EXPERT OPINION ON DRUG SAFETY

IF3.1

2014-10-01

PREAI

Ricci, Francesco; Buzzatti, Giulia; Rubagotti, Alessandra; Boccardo, Francesco

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial 改用阿那曲唑与继续他莫昔芬治疗早期乳腺癌: 意大利他莫昔芬阿那曲唑试验的长期结果

EUROPEAN JOURNAL OF CANCER

IF7.1

2013-05-01

PREAI

Boccardo, F.; Guglielmini, P.; Bordonaro, R.; Fini, A.; Massidda, B.; Porpiglia, M.; Roagna, R.; Serra, P.; Orzalesi, L.; Ucci, G.; Rubagotti, A.

Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death

BMC CANCER

IF3.4

2012-12-28

OAAI

Nuzzo, Pier Vitale; Rubagotti, Alessandra; Zinoli, Linda; Ricci, Francesco; Salvi, Sandra; Boccardo, Simona; Boccardo, Francesco

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

ANNALS OF ONCOLOGY

IF65.4

2012-03-01

169

OAAI

Cognetti, F.; Ruggeri, E. M.; Felici, A.; Gallucci, M.; Muto, G.; Pollera, C. F.; Massidda, B.; Rubagotti, A.; Giannarelli, D.; Boccardo, F.

Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study 血清肠内酯水平与早期乳腺癌女性死亡率的关系: 一项回顾性队列研究

BREAST CANCER RESEARCH AND TREATMENT

IF3

2011-11-18

PREAI

Guglielmini, Pamela; Rubagotti, Alessandra; Boccardo, Francesco

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2011-02-24

PREAI

Boccardo, Francesco; Guglielmini, Pamela; Parodi, Andrea; Rubagotti, Alessandra

An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients

EUROPEAN UROLOGY

IF25.2

2010-02-01

PREAI

Bedognetti, Davide; Rubagotti, Alessandra; Conti, Giario; Francesca, Francesco; De Cobelli, Ottavio; Canclini, Luca; Gallucci, Michele; Aragona, Francesco; Di Tonno, Pasquale; Cortellini, Pietro; Martorana, Giuseppe; Lapini, Alberto; Boccardo, Francesco

Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer

BRITISH JOURNAL OF CANCER

IF6.8

2009-04-28

OAAI

Barboro, P.; Repaci, E.; Rubagotti, A.; Salvi, S.; Boccardo, S.; Spina, B.; Truini, M.; Introini, C.; Puppo, P.; Ferrari, N.; Carmignani, G.; Boccardo, F.; Balbi, C.

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma - Pooled analysis of 2 consecutive trials

CANCER

IF5.1

2007-02-12

OAAI

Boccardo, Francesco; Rubagotti, Alessandra; Aldrighetti, Daniela; Buzz, Franco; Cruciani, Giorgio; Farris, Antonio; Mustacchi, Giorgio; Porpiglia, Mauro; Schieppati, Giorgio; Sismondi, Piero

Switching to aromatase inhibitors in early breast cancer

LANCET

IF88.5

2007-02-01

PREAI

Boccardo, Francesco; Rubagotti, Alessandro

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial 早期乳腺癌改用阿那曲唑与继续他莫昔芬治疗。意大利他莫昔芬阿那曲唑 (ITA) 试验的更新结果

ANNALS OF ONCOLOGY

IF65.4

2006-06-01

167

OAAI

Boccardo, F.; Rubagotti, A.; Guglielmini, P.; Fini, A.; Paladini, G.; Mesiti, M.; Rinaldini, M.; Scali, S.; Porpiglia, M.; Benedetto, C.; Restuccia, N.; Buzzi, F.; Franchi, R.; Massidda, B.; Distante, V.; Amadori, D.; Sismondi, P.

Enterolactone as a risk factor for breast cancer: A review of the published evidence

CLINICA CHIMICA ACTA

IF2.9

2006-03-01

PREAI

Boccardo, F; Puntoni, M; Guglielmini, P; Rubagotti, A

Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG

ANNALS OF ONCOLOGY

IF65.4

2005-12-01

OAAI

Olivieri, A; Santini, G; Patti, C; Chisesi, T; De Souza, C; Rubagotti, A; Aversa, S; Billio, A; Porcellini, A; Candela, M; Centurioni, R; Congiu, AM; Brunori, M; Nati, S; Spriano, M; Vimercati, R; Marino, G; Contu, A; Tedeschi, L; Majolino, I; Crugnola, M; Sertoli, MR

Serum enterolactone levels and the risk of breast cancer in women with palpable cysts

EUROPEAN JOURNAL OF CANCER

IF7.1

2004-01-01

PREAI

Boccardo, F; Lunardi, G; Guglielmini, P; Parodi, M; Murialdo, R; Schettini, G; Rubagotti, A

研究方向